Here were the five most active venture capital firms in healthcare for the fourth quarter of 2017, according to PwC and CB Insights’ Healthcare MoneyTree Report Q4 2017.
1. New Enterprise Associates in Menlo Park, Calif., invested in 13 healthcare companies, including Personal Genome Diagnostics and Allakos.
2. Alexandria Venture Investments in Boston, invested in eight healthcare companies, including Codiak Biosciences and Relay Therapeutics.
3. ARCH Venture Partners in Chicago tied for third, investing in six companies including Semma Therapeutics and GRAIL.
4. OrbiMed Advisors in New York City also invested in six companies during the fourth quarter, including Tricida and Pionyr Inmmunotherapeutics.
5. Atlas Venture in Cambridge, Mass., invested in five companies, including Gemini Therapeutics and Obsidian Therapeutics.
More articles on healthcare:
MedPAC advises Congress to make ASC cost reporting mandatory—8 takeaways
8 statistics on physician salaries—$299k average annual salary
25 statistics on ASC payer mix as a % of collections
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
